Not Before Time, England Announces Conditional Reimbursement Plans
This article was originally published in Scrip
Better late than never: the consultation on what happens next after England's Cancer Drugs Fund finishes on March 31, 2016 is finally out. NHS England and NICE, England's HTA body, have together published proposals that include the conditional reimbursement of promising drugs that under the old system would likely have been thwarted by uncertainties in the evidence supporting them.
Register for our free email digests: